Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery
Phase 4
Withdrawn
- Conditions
- Nail Diseases
- Interventions
- Device: Hydrophilic polymer and potassium ferrate powder
- Registration Number
- NCT04384679
- Lead Sponsor
- Weill Medical College of Cornell University
- Brief Summary
The purpose of this study is to assess the efficacy and safety of topical hemostatic powder containing hydrophilic polymer with potassium ferrate for bleeding control after nail surgical procedures
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- At least 18 years old
- Patients scheduled for any type of nail surgical procedure
- Willingness to participate in the study
- Ability to understand all instructions in the English language
Exclusion Criteria
- Failure to have nail surgery performed
- Likely inability to comply with the study protocol or cooperate fully with the research team
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Hydrophilic polymer and potassium ferrate powder Hydrophilic polymer and potassium ferrate powder Hydrophilic polymer with potassium ferrate powder is applied to the surgical wound with pressure until hemostasis is achieved
- Primary Outcome Measures
Name Time Method Time (in seconds) to bleeding cessation with hydrophilic polymer and potassium ferrate; time (in seconds) to bleeding cessation with direct pressure with sterile gauze Baseline Time (in seconds) will be measured from application of intervention/nonintervention until bleeding cessation
- Secondary Outcome Measures
Name Time Method Number of participants with at least one adverse event End of study (28 days) Adverse events will only include those that are determined to be related to the study device
Trial Locations
- Locations (1)
Weill Cornell Medicine
🇺🇸New York, New York, United States